Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Clinical trial NCT01914757 · COMPLETED
Trial details
- NCT number
- NCT01914757
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 2508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.